Oric Pharmaceuticals, Inc. (ORIC) has 3 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $167K. Most recent filing: Aug. 28, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 28, 2026 filed Aug. 26, 2026 | Piscitelli Dominic Chief Financial Officer | $718,094 | 231,000 | 0% | Yes | |
|
|
||||||
| July 28, 2026 filed July 24, 2026 | Heyman Richard A. Director | −$115,392 | 20,100 | −24% | Yes | |
|
|
||||||
| July 8, 2026 filed July 6, 2026 | Heyman Richard A. Director | −$3,600 | 300 | −0% | Yes | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free